The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
To wrap up the ATMP and Advanced Technologies Track, what could be more fitting than a discussion on the latest advancements in ATMPs? Since the first CAR-T therapy was approved in 2017, the industry, regulators, and even the general public's understanding of ATMPs has grown significantly. With the need for multi-modal facilities and the development of next-generation manufacturing processes and equipment, we face new challenges as well as exciting opportunities. Join us in this session to gain insights into current trends in facility design, process equipment, and emerging platform technologies. Discover how the latest advancements in ATMPs can help you take your business to the next level.
1345 – 1430: Advancing ATMP Platforms by Erich Bozenhardt, Aaron Allen and Charles Heffernan
1430 – 1515: Advances in Multimodal ATMP Facilities by Julie Vickers, Francesca McBride, Peter Cramer and Todd Rumsey
Speaker(s):
Aaron
Allen,
Director, Global Quality,
Moderna Therapeutics